PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-2.72%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$96.6M
AUM Growth
+$96.6M
(+3.5%)
Cap. Flow
-$3.56M
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
$3.56M |
Sector Composition
| 1 | Healthcare | 93.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cartesian Therapeutics
RNAC
$261M
| $38.2M | 39.54% | 1,924,151 | – | – |
|
2
Dare Bioscience
DARE
$27.2M
| $14.6M | 15.1% | 3,287,529 | – | – |
|
|
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
| $10.3M | 10.63% | 1,968,606 | – | – |
|
4
Pulmatrix
PULM
$18M
| $8.59M | 8.89% | 3,607,996 | – | – |
|
5
Fate Therapeutics
FATE
$120M
| $8.01M | 8.29% | 2,473,186 | – | – |
|
|
ATYR
6
aTyr Pharma
ATYR
$527M
| $6.22M | 6.43% | 1,827,992 | – | – |
|
|
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
| $6.02M | 6.23% | 1,875,524 | – | – |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $4.72M | 4.89% | 2,053,540 | – | – |
|
|
9
Ocular Therapeutix
OCUL
$2.12B
| – | – | -383,141 | Closed | -$3.56M |
|